REFERENCES
- Kessler R C, Berglund P A, Bruce M L, et al. The prevalence and correlates of untreated serious mental illness. Health Serv Res 2001; 36: 987–1007, [INFOTRIEVE], [CSA]
- Kessler R C, Berglund P A, Zhao S, . The 12-month prevalence and correlates of serious mental illness. Mental health, United States, R W Manderscheid, M A Sonnenschein, et al. Government Printing Office, Washington, DC 1996; 59–70
- Felker B, Yazel J J, Short D. Mortality and medical comorbidity among psychiatric patients: a review. Psychiatr Serv 1996; 47: 1356–63, [INFOTRIEVE], [CSA]
- Osborn D PJ, Nazareth I, King M B. Risk for coronary heart disease in people with severe mental illness: cross-sectional comparative study in primary care. Br J Psychiatry 2006; 188: 271–7, [INFOTRIEVE], [CSA], [CROSSREF]
- U.S. Department of Health and Human Services. Reducing tobacco use: a report of the surgeon general. Government Printing Office, Washington, DC 1994
- Lasser K, Boyd J W, Woolhandler S, Himmelstein D U, McCormick D, Bor D H. Smoking and mental illness: a population-based prevalence study. JAMA 2000; 284: 2606–10, [INFOTRIEVE], [CSA], [CROSSREF]
- Grant B F, Hasin D S, Chou S P, Stinson F S, Dawson D A. Nicotine dependence and psychiatric disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004; 61: 1107–15, [INFOTRIEVE], [CSA], [CROSSREF]
- Breslau N, Novack S P, Kessler R C. Psychiatric disorders and stages of smoking. Biol Psychiatry 2004; 55: 69–76, [INFOTRIEVE], [CSA], [CROSSREF]
- Goff D C, Henderson D C, Amico E. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am J Psychiatry 1992; 149: 1189–94, [INFOTRIEVE], [CSA]
- Lohr J B, Flynn K. Smoking and schizophrenia. Schizophr Res 1992; 8: 93–102, [INFOTRIEVE], [CSA], [CROSSREF]
- Ziedonis D M, Kosten T R, Glazer W M, et al. Nicotine dependence and schizophrenia. Hosp Community Psychiatry 1994; 45: 204–6, [INFOTRIEVE], [CSA]
- Williams J M, Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav 2004; 29: 1067–83, [INFOTRIEVE], [CSA], [CROSSREF]
- de Leon J, Diaz F J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 2005; 76: 135–57, [INFOTRIEVE], [CSA], [CROSSREF]
- Himelhoch S, Lehman A, Kreyenbuhl J, Daumit G, Brown C, Dixon L. Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. Am J Psychiatry 2004; 161: 2317–9, [INFOTRIEVE], [CSA], [CROSSREF]
- Jones D R, Marcias C, Barreira P J, Fisher W H, Hargreaves W A, Harding C M. Prevalence, severity, and co-occurrence of chronic physical health problems of persons with serious mental illness. Psychiatr Serv 2004; 55: 1250–7, [INFOTRIEVE], [CSA], [CROSSREF]
- Chafetz L, White M C, Collins-Bride G, Nickens J. The poor general health of the severely mentally ill: impact of schizophrenic diagnosis. Community Ment Health J 2005; 41: 169–84, [INFOTRIEVE], [CSA], [CROSSREF]
- Carney C P, Woolson R F, Jones L, Noyes R, Doebbeling B N. Occurrence of cancer among people with mental health claims in an insured population. Psychosom Med 2004; 66: 735–43, [INFOTRIEVE], [CSA], [CROSSREF]
- Daumit G L, Pronovost P J, Anthony C B, Guallar E, Steinwachs D M, Ford D E. Adverse events during medical and surgical hospitalizations for persons with schizophrenia. Arch Gen Psychiatry 2006; 63: 267–72, [INFOTRIEVE], [CSA], [CROSSREF]
- Gonzalez-Pinto A, Gutierrez M, Ezcurra J, et al. Tobacco smoking and bipolar disorder. J Clin Psychiatry 1998; 59: 225–8, [INFOTRIEVE], [CSA]
- Waxmonsky J A, Thomas M R, Miklowitz D J, et al. Prevalence and correlates of tobacco use in bipolar disorder: data from the first 2000 participants in the Systematic Treatment Enhancement Program. Gen Hosp Psychiatry 2005; 27: 321–8, [INFOTRIEVE], [CSA], [CROSSREF]
- Carmody T P. Affect regulation, nicotine addiction, and smoking cessation. J Psychoactive Drugs 1989; 21: 331–42, [INFOTRIEVE], [CSA]
- Dalack G W, Healy D J, Meador-Woodruff J H. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry 1998; 155: 1490–501, [INFOTRIEVE], [CSA]
- Lyon E R. A review of the effects of nicotine on schizophrenia and antipsychotic medications. Psychiatr Serv 1999; 50: 1346–50, [INFOTRIEVE], [CSA]
- Sacco K A, Termine A, Seyal A, et al. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry 2005; 62: 649–59, [INFOTRIEVE], [CSA], [CROSSREF]
- Aguilar M C, Gurpegui M, Diaz F J, de Leon J. Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions. Br J Psychiatry 2005; 186: 215–21, [INFOTRIEVE], [CSA], [CROSSREF]
- Fishman P A, Ebel B E, Garrison M M, Christakis D A, Wieche S E, Rivara F P. Cigarette tax increase and media campaign: cost of reducing smoking-related deaths. Am J Prev Med 2005; 29: 19–26, [INFOTRIEVE], [CSA], [CROSSREF]
- Hu T W, Sung H Y, Keeler T E. Reducing cigarette consumption in California: tobacco taxes vs an anti-smoking media campaign. Am J Pub Health 1995; 85: 1218–22, [INFOTRIEVE], [CSA]
- Siegel M. Mass media antismoking campaigns: a powerful tool for health promotion. Ann Intern Med 1998; 129: 128–32, [INFOTRIEVE], [CSA]
- Biener L, Aseltine R H, Cohen B, Anderka M. Reactions of adult and teenaged smokers to the Massachusetts tobacco tax. Am J Public Health 1998; 88: 1389–91, [INFOTRIEVE], [CSA]
- Centers for Disease Control and Prevention. Preventing tobacco use among young people: a report of the surgeon general. CDC, Atlanta, GA 1994
- Rigotti N A. Treatment of tobacco use and dependence. New Eng J Med 2002; 346: 506–12, [INFOTRIEVE], [CSA], [CROSSREF]
- Prochaska J J, Gill P, Hall S M. Treatment of tobacco use in an inpatient psychiatric setting. Psychiatr Serv 2004; 55: 1265–70, [INFOTRIEVE], [CSA], [CROSSREF]
- Himelhoch S, Daumit G. To whom do psychiatrists offer smoking-cessation counseling?. Am J Psychiatry 2003; 160: 2228–30, [INFOTRIEVE], [CSA], [CROSSREF]
- Spring B, Pingitore R, McChargue D E. Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers. Am J Psychiatry 2003; 160: 316–22, [INFOTRIEVE], [CSA], [CROSSREF]
- Addington J, el-Guebaly N, Addington D, Hodgins D. Readiness to stop smoking in schizophrenia. Can J Psychiatry 1997; 42: 49–52, [INFOTRIEVE], [CSA]
- Esterberg M L, Compton M T. Smoking behavior in persons with a schizophrenia-spectrum disorder: a qualitative investigation of the transtheoretical model. Soc Sci Med 2005; 61: 293–303, [INFOTRIEVE], [CSA], [CROSSREF]
- American Psychiatric Association. Practice guideline for the treatment of patients with nicotine dependence. Am J Psychiatry 1996; 153(suppl)1–31, [CSA]
- el-Guebaly N, Cathcart J, Currie S, Brown D, Gloster S. Public health and therapeutic aspects of smoking bans in mental health and addiction settings. Psychiatr Serv 2002; 53: 1617–22, [INFOTRIEVE], [CSA], [CROSSREF]
- Hartman N, Leong G B, Glynn S M, Wilkins J N, Jarvik M E. Transdermal nicotine and smoking behavior in psychiatric patients. Am J Psychiatry 1991; 148: 374–5, [INFOTRIEVE], [CSA]
- Ziedonis D M, George T P. Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophr Bull 1997; 23: 247–54, [INFOTRIEVE], [CSA]
- Chou K R, Chen R, Lee J F, Ku C H, Lu R B. The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia. Int J Nurs Stud 2004; 41: 321–30, [INFOTRIEVE], [CSA], [CROSSREF]
- Williams J M, Ziedonis D M, Foulds J. A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophrenia. Psychiatr Serv 2004; 55: 1064–6, [INFOTRIEVE], [CSA], [CROSSREF]
- Schroeder S A. What to do with a patient who smokes. JAMA 2005; 294: 482–7, [INFOTRIEVE], [CSA], [CROSSREF]
- Evins A E, Cather C, Deckersbach T, et al. A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. J Clin Psychopharmacol 2005; 25: 218–25, [INFOTRIEVE], [CSA], [CROSSREF]
- Procyshyn R M, Ihsan N, Thompson D. A comparison of smoking behaviours between patients treated with clozapine and depot neuroleptics. Int Clin Psychopharmacol 2001; 16: 291–4, [INFOTRIEVE], [CSA], [CROSSREF]
- de Leon J, Diaz F J, Josiassen R C, Cooper T B, Simpson G M. Does clozapine decrease smoking?. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 757–62, [INFOTRIEVE], [CSA], [CROSSREF]
- George T P, Ziedonis D M, Feingold A, et al. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry 2000; 157: 1835–42, [INFOTRIEVE], [CSA], [CROSSREF]
- Johnson B A, Ait-Daoud N, Akhtar F Z, Javors M A. Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial. Arch Intern Med 2005; 165: 1600–5, [INFOTRIEVE], [CSA], [CROSSREF]
- Addington J, el-Guebaly N, Campbell W, Hodgins D C, Addington D. Smoking cessation treatment for patients with schizophrenia. Am J Psychiatry 1998; 155: 974–5, [INFOTRIEVE], [CSA]
- Weiner E, Ball M P, Summerfelt A, Gold J, Buchanan R W. Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia. Am J Psychiatry 2001; 158: 635–7, [INFOTRIEVE], [CSA], [CROSSREF]
- Miller W R, Rollnick S. Motivational interviewing, 2nd ed. Guilford, New York 2002
- Dunn C, Deroo L, Rivara F P. The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction 2001; 96: 1725–42, [INFOTRIEVE], [CSA], [CROSSREF]
- Burke B L, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol 2003; 71: 843–61, [INFOTRIEVE], [CSA], [CROSSREF]
- Wilson G T, Schlam T R. The transtheoretical model and motivational interviewing in the treatment of eating and weight disorders. Clin Psychol Rev 2004; 24: 361–78, [INFOTRIEVE], [CSA], [CROSSREF]
- Mallin R. Smoking cessation: Integration of behavioral and drug therapies. Am Fam Physician 2002; 65: 1107–14, [INFOTRIEVE], [CSA]
- Steinberg M L, Ziedonis D M, Krejci J A, Brandon T H. Motivational interviewing with personalized feedback: a brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. J Consult Clin Psychol 2004; 72: 723–8, [INFOTRIEVE], [CSA]
- Colby S M, Monti P M, Barnett N P, et al. Brief motivational interviewing in a hospital setting for adolescent smokers: a preliminary study. J Consult Clin Psychol 1998; 66: 574–8, [INFOTRIEVE], [CSA], [CROSSREF]
- Lawendowski L A. A motivational intervention for adolescent smokers. Prev Med 1998; 27: A39–46, [INFOTRIEVE], [CSA], [CROSSREF]
- Brown R A, Ramsey S E, Strong D R, et al. Effects of motivational interviewing on smoking cessation in adolescents with psychiatric disorders. Tob Cont 2003; 12: IV3–10, suppl 4[CSA]
- el-Guebaly N, Cathcart J, Currie S, Brown D, Gloster S. Smoking cessation approaches for persons with mental illness or addictive disorders. Psychiatr Serv 2002; 53: 1166–70, [INFOTRIEVE], [CSA], [CROSSREF]
- Goldstein M G. Bupropion sustained release and smoking cessation. J Clin Psychiatry 1998; 59(suppl 4)66–72, [INFOTRIEVE], [CSA]
- U.S. Public Health Service. A clinical practice guideline for treating tobacco use and dependence. JAMA 2000; 283: 3244–54, [CSA], [CROSSREF]
- Saxon A J, Baer J S, Davis T M, et al. Smoking cessation treatment among dually diagnosed individuals: preliminary evaluation of different pharmacotherapies. Nicotine Tob Res 2003; 5: 589–96, [INFOTRIEVE], [CSA]
- Goff D C, Cather C, Evins A E, et al. Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. J Clin Psychiatry 2005; 66: 183–94, [INFOTRIEVE], [CSA]
- Zullino D F, Delessert D, Eap C B, Preisig M, Baumann P. Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine. Int Clin Psychopharmacol 2002; 17: 141–3, [INFOTRIEVE], [CSA], [CROSSREF]
- Bozikas V P, Papakosta M, Niopas I, Karavatos A, Mirtsou-Fidani V. Smoking impact on CYP1A2 activity in a group of patients with schizophrenia. Eur Neuropsychopharmacol 2004; 14: 39–44, [INFOTRIEVE], [CSA], [CROSSREF]
- de Leon J, Armstrong S C, Cozza K L. The dosing of atypical antipsychotics. Psychosomatics 2005; 46: 262–73, [INFOTRIEVE], [CSA], [CROSSREF]
- Derenne J L, Baldessarini R J. Clozapine toxicity associated with smoking cessation: case report. Am J Ther 2005; 12: 469–71, [INFOTRIEVE], [CSA], [CROSSREF]
- Cooper T B. Clozapine plasma level monitoring: current status. Psychiatr Q 1996; 67: 297–311, [INFOTRIEVE], [CSA], [CROSSREF]
- Peeters A, Barendregt J J, Willekens F, Mackenbach J P, Mamun A A, Bonneux L. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003; 138: 24–32, [INFOTRIEVE], [CSA]
- Allison D B, Fontaine K R, Heo M, et al. The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry 1999; 60: 215–20, [INFOTRIEVE], [CSA]
- Coodin S. Body mass index in persons with schizophrenia. Can J Psychiatry 2001; 46: 549–55, [INFOTRIEVE], [CSA]
- McElroy S L. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002; 63: 207–13, [INFOTRIEVE], [CSA]
- Daumit G L, Clark J M, Steinwachs D M, Graham C M, Lehman A, Ford D E. Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness. J Nerv Ment Dis 2003; 191: 799–805, [INFOTRIEVE], [CSA]
- Weil E, Wachterman M, McCarthy E P, et al. Obesity among adults with disabling conditions. JAMA 2002; 288: 1265–8, [INFOTRIEVE], [CSA], [CROSSREF]
- Daumit G L, Goldberg R W, Anthony C, et al. Physical activity patterns in adults with severe mental illness. J Nerv Ment Dis 2005; 193: 641–6, [INFOTRIEVE], [CSA], [CROSSREF]
- Strassnig M, Brar J S, Ganguli R. Nutritional assessment of patients with schizophrenia: a preliminary study. Schizophr Bull 2003; 29: 393–7, [INFOTRIEVE], [CSA]
- American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004; 27: 596–601, [CSA]
- Dickerson V M. Focus on primary care: Evaluation, management, and treatment of obesity in women. Obstetr Gynecol Surv 2001; 56: 650–63, [CSA], [CROSSREF]
- Strassnig M, Brar J S, Ganguli R. Body mass index and quality of life in community-dwelling patients with schizophrenia. Schizophr Res 2003; 62: 73–6, [INFOTRIEVE], [CSA], [CROSSREF]
- Allison D B, Mentore J L, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156: 1686–96, [INFOTRIEVE], [CSA]
- Baptista T. Body weight gain induced by antipsychotic drugs: mechanisms and management. Acta Psychiatr Scand 2001; 100: 3–16, [CSA]
- Devlin M J, Yanovski S Z, Wilson G T. Obesity: what mental health professionals need to know. Am J Psychiatry 2000; 157: 854–66, [INFOTRIEVE], [CSA], [CROSSREF]
- Zimmermann U, Kraus T, Himmerich H, Schuld A, Pollmächer T. Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J Psychiatr Res 2003; 37: 193–220, [INFOTRIEVE], [CSA], [CROSSREF]
- Keck P E, McElroy S L. Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. J Clin Psychiatry 2004; 64: 1426–35, [CSA]
- Schwartz T L, Nihalani N, Jindal S, Virk S, Jones N. Psychiatric medication-induced obesity: a review. Obes Rev 2004; 5: 115–21, [INFOTRIEVE], [CSA], [CROSSREF]
- Gothelf D, Falk B, Singer P, et al. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. Am J Psychiatry 2002; 159: 1055–7, [INFOTRIEVE], [CSA], [CROSSREF]
- Newcomer J W, Haupt D W, Fucetola R, et al. Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry 2002; 59: 337–45, [INFOTRIEVE], [CSA], [CROSSREF]
- Wirshing D A, Boyd J A, Meng L R, Ballon J S, Marder S R, Wirshing W C. The effects of novel antipsychotics on glucose and lipid levels. J Clin Psychiatry 2002; 63: 856–65, [INFOTRIEVE], [CSA]
- Casey D E, Haupt D W, Newcomer J W, et al. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. J Clin Psychiatry 2004; 65(suppl 7)4–18, [INFOTRIEVE], [CSA]
- Susce M T, Villanueva N, Diaz F J, de Leon J. Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey. J Clin Psychiatry 2005; 66: 167–73, [INFOTRIEVE], [CSA]
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–97, [CSA], [CROSSREF]
- Cohn T, Prud'homme D, Streiner D, Kameh H, Remington G. Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome. Can J Psychiatry 2004; 49: 753–60, [INFOTRIEVE], [CSA]
- Holt R IG, Peveler R C, Byrne C D. Schizophrenia, the metabolic syndrome and diabetes. Diabet Med 2004; 21: 515–23, [INFOTRIEVE], [CSA], [CROSSREF]
- Casey D E. Metabolic issues and cardiovascular disease in patients with psychiatric disorders. Am J Med 2005; 118(suppl 2)15S–22S, [INFOTRIEVE], [CSA]
- Saari K M, Lindeman S M, Viilo K M, et al. A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study. J Clin Psychiatry 2005; 66: 559–63, [INFOTRIEVE], [CSA]
- De Hert M A, van Winkel R, Van Eyck D, et al. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medications. Schizophr Res 2006; 83: 87–93, [INFOTRIEVE], [CSA], [CROSSREF]
- Marder S R, Essock S M, Miller A L, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004; 161: 1334–49, [INFOTRIEVE], [CSA], [CROSSREF]
- McCreadie R G. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry 2003; 183: 534–9, [INFOTRIEVE], [CSA], [CROSSREF]
- McCreadie R, Macdonald E, Blacklock C, et al. Dietary intake of schizophrenic patients in Nithsdale, Scotland: case-control study. Br Med J 1998; 317: 784–5, [CSA]
- Brown S, Birtwistle J, Roe L, Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999; 29: 697–701, [INFOTRIEVE], [CSA], [CROSSREF]
- Elmslie J L, Mann J I, Silverstone J T, Williams S M, Romans S E. Determinants of overweight and obesity in patients with bipolar disorder. J Clin Psychiatry 2001; 62: 486–91, [INFOTRIEVE], [CSA]
- Heiskanen T, Niskanen L, Lyytikäinen R, Saarinen P I, Hintikka J. Metabolic syndrome in patients with schizophrenia. J Clin Psychiatry 2003; 64: 575–9, [INFOTRIEVE], [CSA]
- Birkenaes A B, Søgaard A J, Engh J A, et al. Sociodemographic characteristics and cardiovascular risk factors in patients with severe mental disorders compared with the general population. J Clin Psychiatry 2006; 67: 425–33, [INFOTRIEVE], [CSA]
- Ryan M CM, Thakore J H. Physical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Sci 2002; 71: 239–57, [INFOTRIEVE], [CSA], [CROSSREF]
- Jain A. What works for obesity? A summary of the research behind obesity interventions. BMJ Publishing, London 2004
- Dickerson F B, Pater A, Origoni A E. Health behaviors and health status of older women with schizophrenia. Psychiatr Serv 2002; 53: 882–4, [INFOTRIEVE], [CSA]
- Jacobson D M, Strohecker L, Compton M T, Katz D L. Physical activity counseling in the adult primary care setting: position statement of the American College of Preventive Medicine. Am J Prev Med 2005; 29: 158–62, [INFOTRIEVE], [CSA]
- Barlow S E, Dietz W H. Obesity evaluation and treatment: expert committee recommendations. Pediatrics 1998; 102: 29–39, [CSA], [CROSSREF]
- Desai M M, Rosenheck R A, Druss B G, Perlin J B. Receipt of nutrition and exercise counseling among medical outpatients with psychiatric and substance use disorders. J Gen Intern Med 2002; 17: 556–60, [INFOTRIEVE], [CSA], [CROSSREF]
- Druss B G, Rosenheck R A, Desai M M, Perlin J B. Quality of preventive medical care for patients with mental disorders. Med Care 2002; 40: 129–36, [INFOTRIEVE], [CSA], [CROSSREF]
- Dornelas E A, Wylie-Rosett J, Swencionis C. The DIET study: long-term outcomes of a cognitive-behavioral weight-control intervention in independent-living elders. Dietary intervention: evaluation of technology. J Am Diet Assoc 1998; 98: 1276–81, [INFOTRIEVE], [CSA], [CROSSREF]
- Sbrocco T, Nedegaard R C, Stone J M, Lewis E L. Behavioral choice treatment promotes continuing weight loss: preliminary results of a cognitive-behavioral decision-based treatment for obesity. J Consult Clin Psychol 1999; 67: 260–6, [INFOTRIEVE], [CSA], [CROSSREF]
- Wisotsky W, Swencionis C. Cognitive-behavioral approaches in the management of obesity. Adolesc Med State Art Rev 2003; 14: 37–48, [CSA]
- Swinburn B A, Walter L G, Arroll B, Tilyard M W, Russell D G. The green prescription study: a randomized controlled trial of written exercise advise provided by general practitioners. Am J Public Health 1998; 88: 288–91, [INFOTRIEVE], [CSA]
- Richardson C R. A lifestyle physical activity program for persons with serious mental illness. Psychiatr Serv 2005; 56: 354, [INFOTRIEVE], [CSA], [CROSSREF]
- Richardson C R, Avripas S A, Neal D L, Marcus S M. Increasing lifestyle physical activity in patients with depression or other serious mental illnesses. J Psychiatr Pract 2005; 11: 379–88, [INFOTRIEVE], [CSA], [CROSSREF]
- Richardson C R, Faulkner G, McDevitt J, Skrinar G S, Hutchinson D S, Piette J D. Integrating physical activity into mental health services for persons with serious mental illnesses. Psychiatr Serv 2005; 56: 324–31, [INFOTRIEVE], [CSA], [CROSSREF]
- Weber M, Wyne K. A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schiz Res 2006; 83: 95–101, [CSA], [CROSSREF]
- Hoffmann V P, Ahl J, Meyers A, et al. Wellness intervention for patients with serious and persistent mental illness. J Clin Psychiatry 2005; 66: 1576–9, [INFOTRIEVE], [CSA]
- Meyer T, Broocks A. Therapeutic impact of exercise on psychiatric diseases: guidelines for exercise testing and prescription. Sports Med 2000; 30: 269–79, [INFOTRIEVE], [CSA], [CROSSREF]
- Wyshak G. Women's college physical activity and self-reports of physician-diagnosed depression and of current symptoms of psychiatric distress. J Womens Health Gend Based Med 2001; 10: 363–70, [INFOTRIEVE], [CSA], [CROSSREF]
- Bray S R, Born H A. Transition to university and vigorous physical activity: implications for health and psychological well-being. J Am Coll Health 2004; 52: 181–8, [INFOTRIEVE], [CSA]
- Motl R W, Birnbaum A S, Kubik M Y, Dishman R K. Naturally occurring changes in physical activity are inversely related to depressive symptoms during early adolescence. Psychosom Med 2004; 66: 336–42, [INFOTRIEVE], [CSA], [CROSSREF]
- Saari K, Jokelainen J, Veijola J, et al. Serum lipids in schizophrenia and other functional psychoses: a general population northern Finland 1966 birth cohort survey. Acta Psychiatr Scand 2004; 110: 279–85, [INFOTRIEVE], [CSA], [CROSSREF]
- Archie S, Wilson J H, Osborne S, Hobbs H, McNiven J. Pilot study: access to fitness facility and exercise levels in olanzapine-treated patients. Can J Psychiatry 2003; 48: 628–32, [INFOTRIEVE], [CSA]
- Vreeland B, Minsky S, Menza M, Rigassio Radler D, Roemheld-Hamm B, Stern R. A program for managing weight gain associated with atypical antipsychotics. Psychiatr Serv 2003; 54: 1155–7, [INFOTRIEVE], [CSA], [CROSSREF]
- Brar J S, Ganguli R, Pandina G, Turkoz I, Berry S, Mahmoud R. Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry 2005; 66: 205–12, [INFOTRIEVE], [CSA]
- Kalarchian M A, Marcus M D, Levine M D, et al. Behavioral treatment of obesity in patients taking antipsychotic medications. J Clin Psychiatry 2005; 66: 1058–63, [INFOTRIEVE], [CSA]
- McDevitt J. Primary care update for mental health nurses: evidence-based guidelines for nursing assessment, intervention, and follow-up. J Psychosoc Nurs Ment Health Serv 2004; 42: 22–35, [INFOTRIEVE], [CSA]
- Blackburn G L. Weight gain and antipsychotic medication. J Clin Psychiatry 2000; 61(suppl 8)36–41, [INFOTRIEVE], [CSA]
- Fiore M C, Hatsukami D K, Baker T B. Effective tobacco dependence treatment. JAMA 2002; 288: 1768–71, [INFOTRIEVE], [CSA], [CROSSREF]
- Meyer J M. Treating mind and body in schizophrenia: risks and prevention. CNS Spectr 2004; 9(suppl 11)25–33, [INFOTRIEVE], [CSA]
- Carney C P, Yates W R, Goerdt C J, Doebbeling B N. Psychiatrists' and internists' knowledge and attitudes about delivery of clinical preventive medical services. Psychiatr Serv 1998; 49: 1594–600, [INFOTRIEVE], [CSA]
- Faulkner G, Biddle S. Mental health nursing and the promotion of physical activity. J Psychiatr Ment Health Nurs 2002; 9: 659–65, [INFOTRIEVE], [CSA], [CROSSREF]
- Hyland B, Judd F, Davidson S, Jolley D, Hocking B. Case managers' attitudes to the physical health of their patients. Austr N Z J Psychiatry 2003; 37: 710–4, [CSA], [CROSSREF]
- Perese E F, Perese K. Health problems of women with severe mental illness. J Am Acad Nurse Practit 2003; 15: 212–9, [CSA], [CROSSREF]
- Diaz F J, Rendon D M, Velásquez D M, Susce M T, de Leon J. Smoking and smoking cessation among persons with severe mental illnesses. Psychiatr Serv 2006; 57: 462, [INFOTRIEVE], [CSA], [CROSSREF]